Emergency Medical Services Advisory Committee Meeting

Please note: public comment is now closed. Responses submitted after 5pm on September 30, 2025 will not be reviewed.

Reference of public comment for historical purposes:

Public comment is now open. Responses submitted after 5pm on September 30, 2025 will not be reviewed.

All comments are accepted by filling out the public comment form. Public comment is due by September 30, 2025 at 5pm. All documents are draft versions for the purposes of public comment only and should not be utilized to provide patient care.

Please review the supporting documentation below prior to submitting a public comment:

• EMSAC Policy and Protocol Summary
• 4040-Procedures and Documentation for Non-transported Patients
• 4049-Discontinuing Resuscitative Efforts
• 4050-Death in the Field
• 5001-Trauma Triage
• 2.04-Cardiac Arrest
• 2.10-Poisoning and Overdose
• 2.13-Adult Seizure
• 2.15-Suspected Sepsis
• 2.16-Shock
• 3.02-Decompression Injury
• 3.04-Hazardous Materials
• 4.02-Trauma Arrest
• 7.05-Needle Cricothyrotomy
• 7.09-CO Monitoring
• 11.01-Austere Care
• 11.03-Chemical and Radiological Agents
• 11.05-Blast Injuries
• 14.I Blood Product Management
• 14.I Ketorolac
• 14.I Sodium Bicarb
• 14.I Midazolam
• 14.I Pralidoxime (2-PAM)
• 14.I Activated Charcoal
• Policy 2000 Prehospital Standards and SOP - not available for comment. Admin change contingent on blood product and 2-PAM protocols passing at Oct 2025 EMSAC
• 7.01-Airway Management
• 7.02-ETI
• 7.03-SGA
• 11.02-Crush Syndrome
• 14.I Albuterol
• 14.I Ondansetron (Zofran)
• 14.I Epinephrine
• 14.I Buprenorphine and Naloxone